Skip to main content

Table 1 Baseline characteristics of COVID-19 and CAP patients

From: Comparison of systemic inflammatory profiles in COVID-19 and community-acquired pneumonia patients: a prospective cohort study

Characteristic

All (N = 160)

COVID-19 patients (N = 100)

CAP patients (N = 60)

P-value

Male gender, N (%)

97 (60.6)

65 (65.0)

32 (53.3)

0.20

Age, median (IQR)

60.5 (48.0–71.3)

57.0 (47.8–67.0)

64.0 (54.0–78.3)

0.01

Comorbid conditions, N (%)

 Stroke

5 (3.1)

1 (1.0)

4 (6.7)

0.13

 Myocardial infarction

3 (1.9)

0 (0.0)

3 (5.0)

0.10

 Heart arrhythmia

4 (2.5)

2 (2.0)

2 (3.3)

1.00

 Asthma

2 (1.3)

0 (0.0)

2 (3.3)

0.27

 Bronchiectasis

1 (0.6)

0 (0.0)

1 (1.7)

0.80

 Active cancer

4 (2.5)

1 (1.0)

3 (5.0)

0.30

 Dementia

2 (1.3)

0 (0.0)

2 (3.3)

0.27

 Diabetes mellitus

17 (10.6)

8 (8.0)

9 (15.0)

0.26

 Coronary disease

5 (3.1)

1 (1.0)

4 (6.7)

0.13

 Mental illness

1 (0.6)

1 (1.0)

0 (0.0)

0.80

 Interstitial lung disease

5 (3.1)

1 (1.0)

4 (6.7)

0.13

 Chronic kidney disease

5 (3.1)

1 (1.0)

4 (6.7)

0.13

 Heart failure

2 (1.3)

0 (0.0)

2 (3.3)

0.27

 Arterial hypertension

61 (38.1)

39 (39.0)

22 (36.7)

0.90

 Obesity

6 (3.8)

4 (4.0)

2 (3.3)

0.83

 Supplementary oxygen

8 (5.0)

1 (1.0)

7 (11.7)

0.01

 OSAHS

3 (1.9)

2 (2.0)

1 (1.7)

0.65

 Former/Active smoker

8 (5.0)

6 (6.0)

2 (3.3)

0.71

 Tracheostomy

1 (0.6)

0 (0.0)

1 (1.7)

0.80

 COPD

18 (11.3)

4 (4.0)

14 (23.3)

 < 0.01

 No conditions

62 (38.8)

43 (43.0)

19 (31.7)

0.21

Vital signs at admission, median (IQR)

 Heart rate

90.0 (78.0–103.0)

86.5 (78.0–100.3)

93.5 (78.6–110.5)

0.15

 Respiratory rate

20.0 (18.0–24.3)

20.0 (18.0–25.0)

20.0 (15.0–15.0)

0.88

 Glasgow score

15.0 (15.0–15.0)

15.0 (15.0–15.0)

15.0 (15.0–15.0)

0.01

 Systolic blood pressure

120.0 (105.8–131.0)

121.0 (110.0–131.0)

116.0 (100.0–130.5)

0.20

 Diastolic blood pressure

70.0 (62.8–80.0)

71.5 (65.0–80.0)

70.0 (60.0–80.0)

0,41

Treatments and interventions

 Hospital length of stay, median (IQR)

8.0 (5.0–11.0)

8.0 (5.8–12.3)

7.0 (4.0–11.0)

0.16

 Mechanical ventilation, N (%)

57 (35.6)

41 (41.0)

16 (26.7)

0.10

 ICU admission, N (%)

70 (43.8)

49 (49.0)

21 (35.0)

0.12

 Dexamethasone, N (%)

85 (53.1)

80 (80.0)

5 (8.3)

 < 0.01

 Outcomes, N (%)

 In-hospital mortality

22 (13.8)

17 (17.0)

5 (8.3)

0.19

  1. IQR Interquartile range, OSAHS obstructive sleep apnoea-hypopnea syndrome, COPD chronic obstructive pulmonary disease, ICU intensive care unit